Eckert & Ziegler will open up a radiopharmaceutical production site in the Boston area and it has signed a long-term rental contract for a suitable building in Wilmington, Massachusetts. Mirroring the technology of Eckert & Ziegler’s European plant, it is planned as a first step to produce Yttrium-90, a short-lived radioisotope, which is for example used in oncological applications for the treatment of liver cancer. Previously, in 2019 Eckert & Ziegler had agreed to bring its Y-90 production technology to a partner in Chengdu, China, in return for giving Eckert & Ziegler long-term, exclusive global marketing and sales rights.
To read more please visit:
Source: Bloomberg